Patenting race
Article Abstract:
The strategic use of race as a genetic category is a new phenomenon emerging in biotechnology research and product development to obtain patent protection and drug approval. This introduction of race into the field of patent law as an adjunct to biotechnological inventions would have profound implications for broader scientific and social understandings of race, which also portends a serious distortion of scientific progress, which exist in a balance with commercial considerations.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Patently transparent
Article Abstract:
The ability to interpret and filter intellectual property (IP) has become very important with the proliferation of gene patents and the increasing profusion of biotech patents and licenses with overlapping and competing rights. The Australian startup CAMBIA, and its initiative Biological Innovation for Open Society (BIOS), has created an open-access database collating IP data from many national patent offices that promises to radically improve that process.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: DNA patenting: The end of an era? Trust, patents and public perceptions: the governance of controversial biotechnology research
- Abstracts: Price and volume effects of changes in MSCI indices - nature and causes
- Abstracts: This sporting life. Shedding light on leases. The end of workplace ageism?
- Abstracts: This sporting life. Prepare for change. Constructive concern
- Abstracts: USDA's trade adjustment assistance for farmers: The raspberry industry. Import quotas, price ceilings, and pricing behavior in Taiwan's flour industry